-
MOA of Elitek
- stimulates uridate oxidase
- increase excretion of allantoin
uridate oxidase -----> converts uric acid to allantoin
-
Allopurinol MOA
- inhibits xanthine oxidase (xo)
- inhibits the biotransformation of azathioprine
-
-
Benemid MOA
inhibits organic anion transporter (OAT)
-
inhibition of TNF alpha
- simponi
- enbrel
- humira
- remicade
-
inhibition of IL-1
anakinra, abatacept
-
inhibition of production of IL-2
cyclosporine (all calcineurin inhibitors)
-
inhibition of IMP
Cellcept
-
-
inhibition of dihydrofolate reductase
MTX
-
patient has RA and was given a prescription for a drug with a sig of 3 mg/kg/day at week 0,2,6
Remicade
-
least likely to be experienced/exhibited by a pt who is taking Imuran for management of arthritis
leukocytosis
-
Ms. Zoe has recalcitrant acne which has been managed with Sotret. WOTF is a least likely AE associated with that treatment regimen?
what are the AE associated with this medication?
- mood change
- suicidal ideations
- teratogenicity
- hypothyroidism
- night blindness
- muscoskeletal pain
- dryness of skin and eyes
-
WOTF monoclonal antibodies produces a pharmacological effect by inhibition of IL-6
Tocilizumab (Actemra)
-
Least likely to be an IND of Remicade
Bartters syndrome
-
WOTF is least likely indicated for management of Rosacea
- Orencia (abatacept)
- Benzac wash (not effective against H. Pylori, which is involved in Rosacea
Benzac wash is used in acne bc it can open up pores
-
signs and symptoms of rosacea
- gritty sensation in eyes
- telangiectasia
- red bulbous nose
- papules
- flushing
NO COMEDO IN ROSACEA
-
-
allopurinol
zyloprim, aloprim
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
azelaic acid
finacea, azelax
|
|